To further analyze the role of S100A16 in the pancreatic tumor pathway, we divided the differentially expressed genes into S100A16 high-expressed and low-expressed subgroups and conducted a GSEA pathway enrichment analysis. This evidence concerns the gene S100A16 and pancreatic neoplasm.